In sickle cell disease (SCD) cholesterol metabolism appears dysfunctional as evidenced by abnormal plasma cholesterol content in a subpopulation of SCD patients. Specific activity of the high density lipoprotein (HDL)-bound lecithin cholesterol acyltransferase (LCAT) enzyme, which catalyzes esterification of cholesterol, and generates lysoPC (LPC) was significantly lower in sickle plasma compared to normal. Inhibitory amounts of LPC were present in sickle plasma, and the red blood cell (RBC) lysophosphatidylcholine acyltransferase (LPCAT), essential for the removal of LPC, displayed a broad range of activity. The functionality of sickle HDL appeared to be altered as evidenced by a decreased HDL–Apolipoprotein A-I exchange in sickle plasma as compared to control. Increased levels of oxidized proteins including ApoA-I were detected in sickle plasma. In vitro incubation of sickle plasma with washed erythrocytes affected the ApoA-I-exchange supporting the view that the RBC blood compartment can affect cholesterol metabolism in plasma. HDL functionality appeared to decrease during acute vaso-occlusive episodes in sickle patients and was associated with an increase of secretory PLA2, a marker for increased inflammation. Simvastatin treatment to improve the anti-inflammatory function of HDL did not ameliorate HDL–ApoA-I exchange in sickle patients. Thus, the cumulative effect of an inflammatory and highly oxidative environment in sickle blood contributes to a decrease in cholesterol esterification and HDL function, related to hypocholesterolemia in SCD.
BuchowskiMSSwiftLLAkohoueSAShankarSMFlakollPJAbumradN. Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. J Parenter Enteral Nutr2007; 31: 263–8.
2.
MonnetDKaneFKonan-WaidhetDDiafoukaFSangareAYapoAE. Lipid, apolipoprotein AI and B levels in Ivorian patients with sickle cell anaemia. Ann Biol Clin (Paris)1996; 54: 285–8.
3.
OzturkOHCanYYondenZMotorSOktayGKayaHAslanM. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients. Lipids2013; 48: 1217–26.
4.
RenHGhebremeskelKOkpalaIUgochukwuCCCrawfordMIbegbulamO. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS). Prostaglandins Leukot Essent Fatty Acids2006; 74: 1–6.
5.
SasakiJWatermanMRBuchananGRCottamGL. Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol1983; 5: 35–44.
6.
ShoresJPetersonJVanderJagtDGlewRH. Reduced cholesterol levels in African-American adults with sickle cell disease. J Natl Med Assoc2003; 95: 813–7.
7.
WestermanMP. Hypocholesterolaemia and anaemia. Br J Haematol1975; 31: 87–94.
8.
ZorcaSFreemanLHildesheimMAllenDRemaleyATTaylorJGtKatoGJ. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol2010; 149: 436–45.
9.
HomanREsmaeilNMendelsohnLKatoGJ. A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase. Anal Biochem2013; 441: 80–86.
10.
JainSKShohetSB. Red blood cell [14C]cholesterol exchange and plasma cholesterol esterifying activity of normal and sickle cell blood. Biochim Biophys Acta1982; 688: 11–15.
11.
KucukOLisLJDeyTMataRWestermanMPYachninSSzostekRTracyDKauffmanJWGageDASweeleyCC. The effects of cholesterol oxidation products in sickle and normal red blood cell membranes. Biochim Biophys Acta1992; 1103: 296–302.
12.
AnjumFLazarJSohJAlbitarMGowdaSHussainMMWadgaonkarR. Dysregulation of ubiquitin-proteasome pathway and apolipoprotein A metabolism in sickle cell disease-related pulmonary arterial hypertension. Pulm Circ2013; 3: 851–5.
13.
TumblinATailorAHoehnGTMackAKMendelsohnLFreemanLXuXRemaleyATMunsonPJSuffrediniAFKatoGJ. Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease. Haematologica2010; 95: 1467–72.
14.
YuditskayaSSuffrediniAFKatoGJ. The proteome of sickle cell disease: insights from exploratory proteomic profiling. Expert Rev Proteomics2010; 7: 833–48.
15.
YuditskayaSTumblinAHoehnGTWangGDrakeSKXuXYingSChiAHRemaleyATShenR. F, Munson PJ, Suffredini AF, Kato GJ. Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood2009; 113: 1122–8.
16.
TeslovichTMMusunuruKSmithAVEdmondsonACStylianouIMKosekiMPirruccelloJPRipattiSChasmanDIWillerCJJohansenCTFouchierSWIsaacsAPelosoGMBarbalicMRickettsSLBisJCAulchenkoYSThorleifssonGFeitosaMFChambersJOrho-MelanderMMelanderOJohnsonTLiXGuoXLiMShin ChoYJin GoMJin KimYLeeJYParkTKimKSimXTwee-Hee OngRCroteau-ChonkaDCLangeLASmithJDSongKHua ZhaoJYuanXLuanJLaminaCZieglerAZhangWZeeRYWrightAFWittemanJCWilsonJFWillemsenGWichmannHEWhitfieldJBWaterworthDMWarehamNJWaeberGVollenweiderPVoightBFVitartVUitterlindenAGUdaMTuomilehtoJThompsonJRTanakaTSurakkaIStringhamHMSpectorTDSoranzoNSmitJHSinisaloJSilanderKSijbrandsEJScuteriAScottJSchlessingerDSannaSSalomaaVSaharinenJSabattiCRuokonenARudanIRoseLMRobertsRRiederMPsatyBMPramstallerPPPichlerIPerolaMPenninxBWPedersenNLPattaroCParkerANPareGOostraBAO'DonnellCJNieminenMSNickersonDAMontgomeryGWMeitingerTMcPhersonRMcCarthyMIMcArdleWMassonDMartinNGMarroniFManginoMMagnussonPKLucasGLubenRLoosRJLokkiMLLettreGLangenbergCLaunerLJLakattaEGLaaksonenRKyvikKOKronenbergFKonigIRKhawKTKaprioJKaplanLMJohanssonAJarvelinMRJanssensACIngelssonEIglWKees HovinghGHottengaJJHofmanAHicksAAHengstenbergCHeidIMHaywardCHavulinnaASHastieNDHarrisTBHarituniansTHallASGyllenstenUGuiducciCGroopLCGonzalezEGiegerCFreimerNBFerrucciLErdmannJElliottPEjebeKGDoringADominiczakAFDemissieSDeloukasPde GeusEJde FaireUCrawfordGCollinsFSChenYDCaulfieldMJCampbellHBurttNPBonnycastleLLBoomsmaDIBoekholdtSMBergmanRNBarrosoIBandinelliSBallantyneCMAssimesTLQuertermousTAltshulerDSeielstadMWongTYTaiESFeranilABKuzawaCWAdairLSTaylorHAJrBoreckiIBGabrielSBWilsonJGHolmHThorsteinsdottirUGudnasonVKraussRMMohlkeKLOrdovasJMMunroePBKoonerJSTallARHegeleRAKasteleinJJSchadtEERotterJIBoerwinkleEStrachanDPMooserVStefanssonKReillyMPSamaniNJSchunkertHCupplesLASandhuMSRidkerPMRaderDJvan DuijnCMPeltonenLAbecasisGRBoehnkeMKathiresanS. Biological, clinical and population relevance of 95 loci for blood lipids. Nature2010; 466: 707–13.
17.
FieldingCJShoreVGFieldingPE. Lecithin: cholesterol acyltransferase: effects of substrate composition upon enzyme activity. Biochim Biophys Acta1972; 270: 513–8.
18.
LiuMSubbaiahPV. Activation of plasma lysolecithin acyltransferase reaction by apolipoproteins A-I, C-I and E. Biochim Biophys Acta1993; 1168: 144–52.
19.
NakagawaMNishidaT. Effect of lysolecithin and albumin on lecithin-cholesterol acyltransferase activity in human plasma. J Biochem1973; 74: 1263–6.
20.
NobleRCO’KellyJCMooreJH. Observations on the lecithin: cholesterol acyltransferase system in bovine plasma. Biochim Biophys Acta1972; 270: 519–28.
21.
Nouri-SorkhabiMHSullivanDRRobertsDCKuchelPW. A 31P nuclear magnetic resonance investigation of acyl group transfer from phosphatidylcholine to yield lysophosphatidylcholine in human plasma. Lipids1994; 29: 183–8.
22.
SubbaiahPVChenCHBagdadeJDAlbersJJ. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J Biol Chem1985; 260: 5308–14.
23.
SubbaiahPVBagdadeJD. Demonstration of enzymatic conversion of lysolecithin to lecithin in normal human plasma. Life Sci1978; 22: 1971–7.
24.
AokiJTairaATakanezawaYKishiYHamaKKishimotoTMizunoKSakuKTaguchiRAraiH. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem2002; 277: 48737–44.
25.
Umezu-GotoMKishiYTairaAHamaKDohmaeNTakioKYamoriTMillsGBInoueKAokiJAraiH. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol2002; 158: 227–33.
26.
SubbaiahPVChenCHAlbersJJBagdadeJD. Studies on the cofactor requirement for the acylation and hydrolysis reactions catalyzed by purified lecithin-cholesterol acyltransferase. Effect of low density lipoproteins and apolipoprotein A-i. Atherosclerosis1982; 45: 181–90.
27.
BarlowWMKlopfensteinWE. Effects of constituent fatty acids on the binding of lysophosphatidylcholines by serum albumin. Biochim Biophys Acta1980; 620: 18–23.
SoupeneEKuypersFA. Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem2012; 13: 8–8.
30.
MaeharaK. Membrane cholesterol and insulin receptor in erythrocytes. Fukuoka Igaku Zasshi1991; 82: 586–602.
31.
Nouri-SorkhabiMHSullivanDRKuchelPW. 13C NMR investigation of cholesterol esterification rate in human whole blood. Clin Chim Acta1995; 237: 25–30.
32.
CzarneckaHYokoyamaS. Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem1996; 271: 2023–8.
33.
KuypersFAAndriesseXChildPRoelofsenBOp den KampJAFvan DeenenLLM. The rate of uptake and efflux of phosphatidylcholine from human erythrocytes depends on the fatty acyl composition of the exchanging species. Biochim Biophys Acta1986; 857: 75–84.
34.
BorjaMSNgKFIrwinAHongJWuXIsquithDZhaoXQPrazenBGildengorinVOdaMNVaisarT. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. J Lipid Res2015; 56: 2002–9.
35.
BorjaMSZhaoLHammersonBTangCYangRCarsonNFernandoGLiuXBudamaguntaMSGenestJShearerGCDuclosFOdaMN. HDL-apoA-I exchange: rapid detection and association with atherosclerosis. PLoS One2013; 8: e71541–e71541.
36.
CavigiolioGGeierEGShaoBHeineckeJWOdaMN. Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins. J Biol Chem2010; 285: 18847–57.
37.
HandaDKimuraHOkaTTakechiYOkuhiraKPhillipsMCSaitoH. Kinetic and thermodynamic analyses of spontaneous exchange between high-density lipoprotein-bound and lipid-free apolipoprotein A-I. Biochemistry2015; 54: 1123–31.
38.
VanstewartELongwellBB. Ultramicro methos in biochemistry. 3. The determination of serum cholesterol. Iv. The determination of glucose. Lf-18. Fission Prod Inhal Proj1964; 94: 1–22.
39.
SoupeneEKuypersFA. Ligand binding to the ACBD6 protein regulates the acyl-CoA transferase reactions in membranes. J Lipid Res2015; 56: 1961–71.
40.
MundeeYBigelowNCDavisBHPorterJB. Flow cytometric method for simultaneous assay of foetal haemoglobin containing red cells, reticulocytes and foetal haemoglobin containing reticulocytes. Clin Lab Haematol2001; 23: 149–54.
41.
ZlatkisAZakBBoyleAJ. A new method for the direct determination of serum cholesterol. J Lab Clin Med1953; 41: 486–92.
42.
RouserGFkeischerSYamamotoA. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids1970; 5: 494–6.
43.
SteinbergMHChuiDHDoverGJSebastianiPAlsultanA. Fetal hemoglobin in sickle cell anemia: a glass half full?Blood2014; 123: 481–5.
44.
MuskietFDMuskietFA. Lipids, fatty acids and trace elements in plasma and erythrocytes of pediatric patients with homozygous sickle cell disease. Clin Chim Acta1984; 142: 1–10.
45.
WestermanMPDiloy-PurayMStreczynM. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling. Biochim Biophys Acta1979; 557: 149–55.
46.
SubbaiahPV. Requirement of low density lipoproteins for the lysolecithin acyl transferase activity in human plasma: assay of enzyme activity in abetalipoproteinemic patients. Metabolism1982; 31: 294–8.
47.
SubbaiahPVAlbersJJChenCHBagdadeJD. Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase. J Biol Chem1980; 255: 9275–80.
48.
AlbersJJChenCHAdolphsonJL. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate. J Lipid Res1981; 22: 1206–13.
49.
WangKSubbaiahPV. Importance of the free sulfhydryl groups of lecithin-cholesterol acyltransferase for its sensitivity to oxidative inactivation. Biochim Biophys Acta2000; 1488: 268–77.
50.
WangKSubbaiahPV. Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase. Biochem J2002; 365: 649–57.
51.
SubbaiahPVLiuM. Disparate effects of oxidation on plasma acyltransferase activities: inhibition of cholesterol esterification but stimulation of transesterification of oxidized phospholipids. Biochim Biophys Acta1996; 1301: 115–26.
52.
AnsellBJWatsonKEFogelmanAMNavabMFonarowGC. High-density lipoprotein function recent advances. J Am Coll Cardiol2005; 46: 1792–8.
AdamSSHoppeC. Potential role for statins in sickle cell disease. Pediatr Blood Cancer2013; 60: 550–7.
55.
Bereal-WilliamsCMachadoRFMcGowanV2ndChiAHunterCJKatoGJHunterLDalbyCKHauserKPTailorACannonRO3rd. Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia. Haematologica2012; 97: 1768–70.
56.
HoppeCKuypersFLarkinSHagarWVichinskyEStylesL. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol2011; 153: 655–63.
57.
AnsellBJ. Targeting the anti-inflammatory effects of high-density lipoprotein. Am J Cardiol2007; 100: n3–9.
58.
AnsellBJNavabMHamaSKamranpourNFonarowGHoughGRahmaniSMottahedehRDaveRReddySTFogelmanAM. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation2003; 108: 2751–6.
59.
CurcicSHolzerMFreiRPasterkLSchichoRHeinemannAMarscheG. Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL. Biochim Biophys Acta2015; 1851: 184–93.
60.
TietgeUJMaugeaisCLund-KatzSGrassDdeBeerFCRaderDJ. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice. Arterioscler Thromb Vasc Biol2002; 22: 1213–8.
61.
RohrerLHersbergerMvon EckardsteinA. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol2004; 15: 269–78.
62.
AtagaKIHinderliterABrittainJEJonesSXuHCaiJKimSPritchardKAHilleryCA. Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease. Hematology2015; 20: 289–96.
63.
KuypersFAStylesLA. The role of secretory phospholipase A2 in acute chest syndrome. Cell Mol Biol (Noisy-le-grand)2004; 50: 87–94.
RaghavachariNXuXMunsonPJGladwinMT. Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease. PLoS One2009; 4: e6484–e6484.
66.
SteinmetzAHockeGSaileRPuchoisPFruchartJC. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta1989; 1006: 173–8.
67.
EndresMLaufsU. Effects of statins on endothelium and signaling mechanisms. Stroke2004; 35: 2708–11.
68.
HebbelRPOsarogiagbonRKaulD. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation2004; 11: 129–51.
69.
LeferAMScaliaRLeferDJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res2001; 49: 281–7.
70.
LeferDJJonesSPGirodWGBainesAGrishamMBCockrellASHuangPLScaliaR. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol1999; 276: H1943–50.
71.
JiXXuHZhangHHilleryCAGaoHQPritchardKAJr. Anion exchange HPLC isolation of high-density lipoprotein (HDL) and on-line estimation of proinflammatory HDL. PLoS One2014; 9: e91089–e91089.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
